-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KKr8Z+4hZstUumbQhdEp2wZcFbEiZgdz/uZcvHRtEFyZiC4Dt8JqOdvnjbBxcmll maM3zetw/zrzUeLMZlZVTA== 0001104659-06-019513.txt : 20060327 0001104659-06-019513.hdr.sgml : 20060327 20060327170943 ACCESSION NUMBER: 0001104659-06-019513 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060321 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing ITEM INFORMATION: Temporary Suspension of Trading Under Registrant's Employee Benefit Plans ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060327 DATE AS OF CHANGE: 20060327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURES SUNSHINE PRODUCTS INC CENTRAL INDEX KEY: 0000275053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870327982 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08707 FILM NUMBER: 06712572 BUSINESS ADDRESS: STREET 1: 75 E 1700 SOUTH CITY: PROVO STATE: UT ZIP: 84606 BUSINESS PHONE: 8013424300 MAIL ADDRESS: STREET 2: 75 EAST 1700 SOUTH CITY: PROVO STATE: UT ZIP: 84606 FORMER COMPANY: FORMER CONFORMED NAME: AMTEC INDUSTRIES INC DATE OF NAME CHANGE: 19821108 8-K 1 a06-7718_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

United States

Securities and Exchange Commission

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  March 21, 2006

 

Nature’s Sunshine Products, Inc.

(Exact name of registrant as specified in its charter)

 

Utah

 

0-8707

 

87-0327982

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification
Number)

 

 

 

 

 

75 East 1700 South

Provo, Utah 84606

(Address of principal executive offices) (Zip Code)

 

(801) 342-4300

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 to Form 8-K):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 24.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 40.13e-4(c))

 

 



 

Item 3.01                     Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On March 24, 2006, Nature’s Sunshine Products, Inc. issued a press release announcing that, on March 21, 2006, the Company had received notice from The Nasdaq Stock Market that, because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005 had not been timely filed, the Company is not in compliance with Marketplace Rule 4310(c)(14).  As was previously disclosed, the Company has not been in compliance with Nasdaq Marketplace Rule 4310(c)(14) because it has not filed a complete quarterly report on Form 10-Q for the quarter ended September 30, 2005 and the Company’s delayed filing of its Form 10-K serves as an additional basis for delisting the Company’s common stock from the Nasdaq National Market.

 

The Company has previously disclosed in filings with the Securities and Exchange Commission that, because of issues raised in the Company’s ongoing internal investigation, the Company does not expect to be able to file its September 30, 2005 10-Q by March 31, 2006, which is the deadline of the extension to file granted by the Nasdaq Listing Qualifications Panel to the Company.  In addition, the Company does not expect to file its annual report on Form 10-K for the fiscal year ended December 31, 2005 on or before March 31, 2006.  The Company intends to consider seeking an extension from Nasdaq to file both the Form 10-Q and the Form10-K.  However, no assurance can be made that the Company will be granted any further extension and, therefore, the Company’s common stock may be subject to delisting from the Nasdaq National Market.  If the Company’s common stock is delisted from the Nasdaq National Market, the liquidity of its common stock would be adversely impacted and the Company may experience other adverse consequences resulting from the delisting and the failure to file periodic reports.

 

A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 5.04                     Temporary Suspension of Trading Under Registrant’s Employee Benefit Plan.

 

In light of the March 18, 2006 determination by the Audit Committee that investors should not rely upon certain previously-issued financial statements, as reflected in the Company’s Current Report on From 8-K filed on March 20, 2006, on March 24, 2006, pursuant to Regulation BTR, the Company sent notices to its directors and executive officers notifying them that, in connection with these events, future purchases of the Company’s common stock under the Company’s 401(k) Plan and the 1995 Stock Option Plan (the “Plans”) were suspended.  The Company has also advised participants in the Plans of this suspension.  The suspension is necessary because the Company has been determined that the Registration Statements on Form S-8 covering shares of the Company’s common stock acquired in connection with the Plan should not be available for use until the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2005 (the “2005 Form 10-K”) and any necessary restatements are filed with the Securities and Exchange Commission (the “SEC”).

 

The Company determined that it was unable to give advance notice of the suspension to the directors and executive officers due to events in connection with the Company’s ongoing internal investigation that were unforeseeable by the Company.

 

2



 

The suspension for participants in the Plans began on March 23, 2006 and will end on the day in which the Company’s 2005 Form 10-K is filed and any necessary restatements of previously filed financial statements are filed with the SEC.  It is not currently known when the 2005 Form 10-K or any restatements of the Company’s financial statements will be filed.  Inquiries regarding the suspension and the notice pursuant to Regulation BTR should be directed to the Company’s Chief Executive Officer at 801-342-4300 or 75 East 1700 South, Provo, Utah 84606.

 

Item 9.01                     Financial Statements and Exhibits.

 

(d)           The following exhibit is being furnished herewith:

 

99.1         Press release issued by the Company dated March 24, 2006.

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

March 27, 2006

 

By:

 

 NATURE’S SUNSHINE PRODUCTS, INC.

 

 

 

 

 

 

 

 

 

 /s/ Douglas Faggioli

 

 

Name:

 

 Douglas Faggioli

 

 

Title:

 

 President, Chief Executive Officer and Director

 

4



 

EXHIBIT INDEX

 

Number

 

Exhibit

 

 

 

99.1

 

Text of press release issued by Nature’s Sunshine Products, Inc. dated March 24, 2006.

 

5


EX-99.1 2 a06-7718_1ex99d1.htm EXHIBIT 99

Exhibit 99.1

 

NATURE’S SUNSHINE PRODUCTS REPORTS RECEIPT OF NONCOMPLIANCE NOTICE FROM NASDAQ

 

PROVO, UTAH, March 24, 2006 – Nature’s Sunshine Products Inc. (NASDAQ:NATRE) announced today that, on March 21, 2006, it received notice from The Nasdaq Stock Market that, because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2005 was not filed with the Securities and Exchange Commission by March 16, 2006, the Company is not in compliance with Marketplace Rule 4310(c)(14). As was previously disclosed, the Company has not been in compliance with Nasdaq Marketplace Rule 4310(c)(14) because it has not filed a complete quarterly report on Form 10-Q for the quarter ended September 30, 2005. However, the Nasdaq Listing Qualifications Panel granted the Company an extension until March 31, 2006 to file its complete Form 10-Q. The Company’s delayed filing of its Form 10-K serves as an additional basis for delisting the Company’s common stock from the Nasdaq National Market.

 

The Company has previously disclosed in filings with the Securities and Exchange Commission that, because of issues raised in the Company’s ongoing internal investigation, the Company does not expect to be able to meet the March 31, 2006 10-Q filing deadline set by the Panel for filing the Company’s September 30, 2005 Form 10-Q nor does the Company expect to file its annual report on Form 10-K for the fiscal year ended December 31, 2005 on or before March 31, 2006. The Company intends to consider seeking an extension to file both the Form 10-Q and the Form10-K. However, no assurance can be made that the Company will be granted any further extension and, therefore, the Company’s common stock may be subject to delisting from the Nasdaq National Market. If the Company’s common stock is delisted from the Nasdaq National Market, the liquidity of its common stock would be adversely impacted and the Company may experience other adverse consequences resulting from the delisting and the failure to file periodic reports.

 

About Nature’s Sunshine

 

Nature’s Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom and Ireland, Colombia, Brazil, Thailand, Israel, Singapore and Taiwan. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, Norway, and the Russian Federation.

 

Statements in this press release concerning the Company’s request to remain listed and its anticipated filing of periodic reports with the Securities and Exchange Commission, together with other statements that are not historical facts, are “forward-looking statements” as that term is defined under Federal Securities Laws. “Forward-looking statements” are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from those set forth in such statements. Such risks, uncertainties, and factors include, but are not limited to, the results of the Company’s ongoing internal investigation, the impact of the delisting of the Company’s common stock and failure to file periodic reports and foreign business risks, as well as other risks detailed in the Company’s filings with the Securities and Exchange Commission. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this press release.

 



 

Contact:

Craig D. Huff

 

Steven S. Anreder

Chief Financial Officer

 

Anreder & Co.

Nature’s Sunshine Products, Inc.

 

10 East 40th Street, Suite1308

Provo, Utah 84605-9005

 

New York, NY 10016

(801) 342-4370

 

(212) 532-3232

 

###

 


-----END PRIVACY-ENHANCED MESSAGE-----